NCT07434167

Brief Summary

Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
4mo left

Started Mar 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Mar 2026Dec 2026

First Submitted

Initial submission to the registry

February 5, 2026

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 25, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

March 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

February 25, 2026

Status Verified

February 1, 2026

Enrollment Period

9 months

First QC Date

February 5, 2026

Last Update Submit

February 22, 2026

Conditions

Keywords

MetaverseExtended Reality (XR)Digital TwinLocalization of Pulmonary Nodulesuniportal VATS

Outcome Measures

Primary Outcomes (1)

  • Localization accuracy

    Procedures in this study will be conducted in a CT room. The accuracy of XR-assisted CT-guided localization will be assessed immediately after localization by employing in-room CT to determine the needle tip position and measure the distance to the target tumor.

    Immediatedly after Extended Reality (XR)-Assisted CT-Guided Localization

Secondary Outcomes (1)

  • Assessment of perioperative outcomes

    The study assessment time frame from XR-assisted CT-guided localization to discharge is approximately 3 to 7 days.

Study Arms (1)

Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules

EXPERIMENTAL
Procedure: Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules

Interventions

This study plans to collect approximately 30 localization cases from multiple centers within our institution. First, after patient positioning and immobilization in the computed tomography (CT) suite, a chest CT scan is performed. Imaging data are processed using semi-automatic segmentation and rapid reconstruction techniques to generate, in real time, a three-dimensional model that corresponds to the patient's current localization position. During the construction of the three-dimensional model, patients remain in a fixed position. To reduce anxiety and discomfort associated with waiting, patient education related to pulmonary nodule localization and thoracoscopic surgery is provided during this period. The educational content includes the purpose of the procedure, procedural steps, potential risks, and key points of postoperative care. Once model construction is completed, a metaverse-based XR platform is used in the same setting to overlay the digital twin model onto the patient's

Extended Reality (XR)-Assisted CT Localization of Pulmonary Nodules

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 18 and 80 who are scheduled to undergo lung nodule resection surgery.
  • Patients with lung nodules smaller than 2 cm that require preoperative localization.
  • Patients with lung nodules located in the outer one-third of the lung.

You may not qualify if:

  • Patients requiring lobectomy.
  • Patients who have not provided written informed consent.
  • Vulnerable populations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Lung Neoplasms

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 5, 2026

First Posted

February 25, 2026

Study Start

March 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

February 25, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

De-identified individual participant data (IPD) collected during this study will generally not be shared with other researchers, primarily due to patient privacy considerations. However, limited access to de-identified IPD may be considered in exceptional cases upon a reasonable request.